These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19122792)

  • 1. Statistical learning of origin-specific statically optimal individualized treatment rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 6. PubMed ID: 19122792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal effect models for realistic individualized treatment and intention to treat rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized treatment rules: generating candidate clinical trials.
    Petersen ML; Deeks SG; van der Laan MJ
    Stat Med; 2007 Nov; 26(25):4578-601. PubMed ID: 17450501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal Structural Models with Counterfactual Effect Modifiers.
    Zheng W; Luo Z; van der Laan MJ
    Int J Biostat; 2018 Jun; 14(1):. PubMed ID: 29883322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted maximum likelihood based causal inference: Part I.
    van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 2. PubMed ID: 21969992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly Robust and Efficient Estimation of Marginal Structural Models for the Hazard Function.
    Zheng W; Petersen M; van der Laan MJ
    Int J Biostat; 2016 May; 12(1):233-52. PubMed ID: 27227723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
    Orellana L; Rotnitzky A; Robins JM
    Int J Biostat; 2010; 6(2):Article 8. PubMed ID: 21969994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust regression for optimal individualized treatment rules.
    Xiao W; Zhang HH; Lu W
    Stat Med; 2019 May; 38(11):2059-2073. PubMed ID: 30740747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models.
    Petersen M; Schwab J; Gruber S; Blaser N; Schomaker M; van der Laan M
    J Causal Inference; 2014 Jun; 2(2):147-185. PubMed ID: 25909047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History-adjusted marginal structural models for estimating time-varying effect modification.
    Petersen ML; Deeks SG; Martin JN; van der Laan MJ
    Am J Epidemiol; 2007 Nov; 166(9):985-93. PubMed ID: 17875580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted maximum likelihood based causal inference: Part II.
    van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 3. PubMed ID: 21731531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.
    Butler EL; Laber EB; Davis SM; Kosorok MR
    Biometrics; 2018 Mar; 74(1):18-26. PubMed ID: 28742260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules.
    Bembom O; van der Laan MJ
    Stat Med; 2008 Aug; 27(19):3689-716. PubMed ID: 18407580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted minimum loss based estimator that outperforms a given estimator.
    Gruber S; van der Laan MJ
    Int J Biostat; 2012 May; 8(1):Article 11. PubMed ID: 22628356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian analysis of complex interacting mutations in HIV drug resistance and cross-resistance.
    Kozyryev I; Zhang J
    Adv Exp Med Biol; 2015; 827():367-83. PubMed ID: 25387976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times.
    Coulombe J; Moodie EE; Shortreed SM; Renoux C
    Stat Methods Med Res; 2023 May; 32(5):868-884. PubMed ID: 36927216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule.
    van der Laan MJ; Luedtke AR
    J Causal Inference; 2015 Mar; 3(1):61-95. PubMed ID: 26236571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.